The presence of tiapride above 0.3 ppm in vigabatrin products may theoretically lead to numerous serious and life‑threatening adverse reactions; a risk to the patient’s health or life cannot be excluded. Potential effects: serious adverse reactions, including life‑threatening events.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from the listed batches. Patients should check the batch numbers and, if they have these packs, return them to a pharmacy; if the medicine from these batches has been used, they...
Withdrawal from the market throughout the country of SABRIL medicinal product batches 2987B and 1993A, and granting the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related